Intracranial Atherosclerosis: The Natural History and Management Strategies


Intracranial atherosclerotic disease (ICAD) represents a major cause of stroke and transient ischemic attacks. The prevalence and natural course of ICAD are closely related to race and ethnicity. The best treatment for ICAD is a crucial issue; data from recent trials indicate that aggressive medical management and life style modifications are better than endovascular treatments for prevention of recurrent stroke in high-risk patients with ICAD. Endovascular treatment is still an option for subgroup of patients who are not responded to optimal medical therapy.

Share and Cite:

Mansour, O. , Schumacher, M. , Farrag, M. and Abd-Allah, F. (2014) Intracranial Atherosclerosis: The Natural History and Management Strategies. World Journal of Cardiovascular Diseases, 4, 350-360. doi: 10.4236/wjcd.2014.47044.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Taylor, T.N., Davis, P.H., Torner, J.C., Holmes, J., Meyer, J.W. and Jacobson, M.F. (1996) Lifetime Cost of Stroke in the United States. Stroke, 27, 1459-1466.
[2] Wityk, R.J., Lehman, D., Klag, M., Coresh, J., Ahn, H. and Litt, B. (1996) Race and Sex Differences in the Distribution of Cerebral Atherosclerosis. Stroke, 27, 1974-1980.
[3] White, H., Boden-Albala, B., Wang, C.L., Elkind, M.S.V., Rundek, T., Wright, C.B. and Sacco, R.L. (2005) Ischemic Stroke Subtype Incidence among Whites, Blacks, and Hispanics: The Northern Manhattan Study. Circulation, 111, 1327-1331.
[4] Qureshi, A.I., Feldmann, E., Gomez, C.R., Johnston, S.C., Kasner, S.E., Quick, D.C., Rasmussen, P.A., Fareed, M., Suri, K., Taylor, R.A. and Zaidat, O.O. (2009) Intracranial Atherosclerotic Disease: An Update. Annals of Neurology, 66, 730-738.
[5] Chimowitz, M.I., Lynn, M.J., Howlett-Smith, H., Stern, B.J., Hertzberg, V.S., Frankel, M.R., Levine, S.R., Chaturvedi, S., Kasner, S.E., Benesch, C.G., Sila, C.A., Jovin, T.G. and Romano, J.G. (2005) Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis. New England Journal of Medicine, 352, 1305-1316.
[6] Siddiq, F., Memon, M.Z., Vazquez, G., Safdar, A. and Qureshi, A.I. (2009) Comparison between Primary Angioplasty and Stent Placement for Symptomatic Intracranial Atherosclerotic Disease: Meta-Analysis of Case Series. Neurosurgery, 65, 1024.
[7] Bose, A., Hartmann, M., Henkes, H., Liu, H.M., Teng, M.M.H., Szikora, I., Berlis, A., Reul, J., Yu, S.C.H., Forsting, M., Lui, M., Lim, W. and Sit, S.P. (2007) A Novel, Self-Expanding, Nitinol Stent in Medically Refractory Intracranial Atherosclerotic Stenoses. Stroke, 38, 1531-1537.
[8] Eberhardt, O., Naegele, T., Raygrotzki, S., Weller, M. and Ernemann, U. (2006) Stenting of Vertebrobasilar Arteries in Symptomatic Atherosclerotic Disease and Acute Occlusion: Case Series and Review of the Literature. Journal of Vascular Surgery, 43, 1145-1154.
[9] Akins, P.T., Pilgram, T.K., Cross III, DeWitte T. and Moran, C.J. (1998) Natural History of Stenosis from Intracranial Atherosclerosis by Serial Angiography. Stroke, 29, 433-438.
[10] Kwon, S.U., Cho, Y.-J., Koo, J.-S., Bae, H.-J., Lee, Y.-S., Hong, K.-S., Lee, J.H. and Kim, J.S. (2005) Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial Stenosis: The Multicenter Double-Blind Placebo-Controlled Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis. Stroke, 36, 782-786.
[11] Lee, Y.S., Bae, H.-J., Kang, D.-W., Lee, S.-H., Yu, K., Park, J.-M., Cho, Y.-J., Hong, K.-S., Kim, D.-E., Kwon, S.U., Lee, K.B., Rha, J.-H., Koo, J., Han, M.-G., Lee, S.J., Lee, J.-H., Jung, S.W., Lee, B.-C. and Kim, J.S. (2011) Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): A Randomized Double-Blind Non-Inferiority Trial. Cerebrovascular Diseases, 32, 65-71.
[12] Kasner, S.E., Chimowitz, M.I., Lynn, M.J., Howlett-Smith, H., Stern, B.J., Hertzberg, V.S., Frankel, M.R., Levine, S.R., Chaturvedi, S., Benesch, C.G., Sila, C.A., Jovin, T.G., Romano, J.G. and Cloft, H.J. (2006) Predictors of Ischemic Stroke in the Territory of a Symptomatic Intracranial Arterial Stenosis. Circulation, 113, 555-563.
[13] Mazighi, M., Tanasescu, R., Ducrocq, X., Vicaut, E., Bracard, S., Houdart, E. and Woimant, F. (2006) Prospective Study of Symptomatic Atherothrombotic Intracranial Stenoses. Neurology, 66, 1187-1191.
[14] Liebeskind, D.S., Cotsonis, G.A., Saver, J.L., Lynn, M.J., Cloft, H.J. and Chimowitz, M.I. (2011) Collateral Circulation in Symptomatic Intracranial Atherosclerosis. Journal of Cerebral Blood Flow & Metabolism, 31, 1293-1301.
[15] Wong, K.S., Gao, S., Chan, Y.L., Hansberg, T., Lam, W.W.M., Droste, D.W., Kay, R. and Ringelstein, E.B. (2002) Mechanisms of Acute Cerebral Infarctions in Patients with Middle Cerebral Artery Stenosis: A Diffusion-Weighted Imaging and Microemboli Monitoring Study. Annals of Neurology, 52, 74-81.
[16] Del Sette, M., Eliasziw, M., Streifler, J.Y., Hachinski, V.C., Fox, A.J. and Barnett, H.J. (2000) Internal Borderzone Infarction: A Marker for Severe Stenosis in Patients with Symptomatic Internal Carotid Artery Disease. For the North American Symptomatic Carotid Endarterectomy (NASCET) Group. Stroke, 31, 631-636.
[17] Caplan, L.R. (1989) Intracranial Branch Atheromatous Disease A Neglected, Understudied, and Underused Concept. Neurology, 39, 1246-1246.
[18] Derdeyn, C.P., Grubb, R.L. and Powers, W.J. (1999) Cerebral Hemodynamic Impairment, Methods of Measurement and Association with Stroke Risk. Neurology, 53, 251-251.
[19] Yamauchi, H., Nishii, R., Higashi, T., Kagawa, S. and Fukuyama, H. (2009) Hemodynamic Compromise as a Cause of Internal Border-Zone Infarction and Cortical Neuronal Damage in Atherosclerotic Middle Cerebral Artery Disease. Stroke, 40, 3730-3735.
[20] Naritomi, H., Sawada, T., Kuriyama, Y., Kinugawa, H., Kaneko, T. and Takamiya, M. (1985) Effect of Chronic Middle Cerebral Artery Stenosis on the Local Cerebral Hemodynamics. Stroke, 16, 214-219.
[21] Kim, Y.D., Cha, M.J., Kim, J., Lee, D.H., Lee, H.S., Nam, C.M., et al. (2011) Increases in Cerebral Atherosclerosis According to CHADS2 Scores in Patients with Stroke with Nonvalvular Atrial Fibrillation. Stroke, 42, 930-934.
[22] Lee, D.K., Kim, J.S., Kwon, S.U., Yoo, S.H. and Kang, D.W. (2005) Lesion Patterns and Stroke Mechanism in Atherosclerotic Middle Cerebral Artery Disease: Early Diffusion-Weighted Imaging Study. Stroke, 36, 2583-2588.
[23] Pico, F., Labreuche, J., Cohen, A., Touboul, P.J. and Amarenco, P. (2004) Intracranial Arterial Dolichoectasia Is Associated with Enlarged Descending Thoracic Aorta. Neurology, 63, 2016-2021.
[24] Smoker, W.R., Price, M.J., Keyes, W.D., Corbett, J.J. and Gentry, L.R. (1986) High-Resolution Computed Tomography of the Basilar Artery: 1. Normal Size and Position. American Journal of Neuroradiology, 7, 55-60.
[25] Hennerici, M., Rautenberg, W., Sitzer, G. and Schwartz, A. (1987) Transcranial Doppler Ultrasound for the Assessment of Intracranial Arterial Flow Velocity—Part 1. Examination Technique and Normal Values. Surgical Neurology, 27, 439-448.
[26] Caplan, L.R. (2005) Dilatative Arteriopathy (Dolichoectasia): What Is Known and Not Known. Annals of Neurology, 57, 469-471.
[27] He, J., Whelton, P.K., Vu, B. and Klag, M.J. (1998) Aspirin and Risk of Hemorrhagic Stroke: A Meta-Analysis of Randomized Controlled Trials. JAMA, 280, 1930-1935.
[28] Alazzaz, A., Thornton, J., Aletich, V.A., Debrun, G.M., Ausman, J.I. and Charbel, F. (2000) Intracranial Percutaneous Transluminal Angioplasty for Arteriosclerotic Stenosis. Archives of Neurology, 57, 1625-1630.
[29] Connors 3rd, J.J. and Wojak, J.C. (1999) Percutaneous Transluminal Angioplasty for Intracranial Atherosclerotic Lesions: Evolution of Technique and Short-Term Results. Journal of Neurosurgery, 91, 415-423.
[30] Fiorella, D., Masaryk, T.J. and Turk, A.S. (2010) Technical Aspects of Intracranial Angioplasty and Stenting. Cerebral Revascularization: Microsurgical and Endovascular Techniques.
[31] Yu, S.C., Leung, T.W., Hung, E.H., Lee, K.T. and Wong, L.K. (2012) Angioplasty and Stenting for Intracranial Atherosclerotic Stenosis with Nitinol Stent: Factors Affecting Technical Success and Patient Safety. Neurosurgery, 70, ons104-ons113.
[32] Zhao, Z.W., Deng, J.P., He, S.M., Qin, H.Z., Gao, L. and Gao, G.D. (2009) Intracranial Angioplasty with Gateway-Wingspan System for Symptomatic Atherosclerotic Stenosis: Preliminary Results of 27 Chinese Patients. Surgical Neurology, 72, 607-611.
[33] Sundt Jr., T.M., Smith, H.C., Campbell, J.K., Vlietstra, R.E., Cucchiara, R.F., Stanson, A.W. (1980) Transluminal Angioplasty for Basilar Artery Stenosis. Mayo Clinic Proceedings, 55, 673-680.
[34] Callahan 3rd, A.S. and Berger, B.L. (1997) Balloon Angioplasty of Intracranial Arteries for Stroke Prevention. Journal of Neuroimaging, 7, 232-235.
[35] Marks, M.P., Marcellus, M., Norbash, A.M., Steinberg, G.K., Tong, D. and Albers, G.W. (1999) Outcome of Angioplasty for Atherosclerotic Intracranial Stenosis. Stroke, 30, 1065-1069.
[36] Connors 3rd, J.J. and Wojak, J.C. (1999) Percutaneous Transluminal Angioplasty for Intracranial Atherosclerotic Lesions: Evolution of Technique and Short-Term Results. Journal of Neurosurgery, 91, 415-423.
[37] Nahser, H.C., Henkes, H., Weber, W., Berg-Dammer, E., Yousry, T.A. and Kühne, D. (2000) Intracranial Vertebrobasilar Stenosis: Angioplasty and Follow-Up. American Journal of Neuroradiology, 21, 1293-1301.
[38] Marks, M.P., Marcellus, M.L., Do, H.M., Schraedley-Desmond, P.K., Steinberg, G.K., Tong, D.C., et al. (2005) Intracranial Angioplasty without Stenting for Symptomatic Atherosclerotic Stenosis: Long-Term Follow-Up. American Journal of Neuroradiology, 26, 525-530.
[39] Qureshi, A.I. (2012) Interpretation and Implications of the Prematurely Terminated Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in the Intracranial Stenosis (SAMMPRIS) Trial. Neurosurgery, 70, E264-E268.
[40] Tarr, R.W., Albuquerque, F., Hirsh, J. and Prestigiacomo, C. (2011) The SAMMPRIS Trial: The End or Just the Beginning. Journal of Neurointerventional Surgery, 3, 310-311.
[41] Mori, T., et al. (1997) Percutaneous Transluminal Cerebral Angioplasty: Serial Angiographic Follow-Up after Successful Dilatation. Neuroradiology, 39, 111-116.
[42] Powers, W.J., Clarke, W.R., Grubb Jr., R.L., Videen, T.O., Adams Jr., H.P., Derdeyn, C.P. (2011) Extracranial-Intra-cranial Bypass Surgery for Stroke Prevention in Hemodynamic Cerebral Ischemia: The Carotid Occlusion Surgery Study Randomized Trial. JAMA, 306, 1983-1992.
[43] Platform, I.C.T.R. (2012) Early Stent-Assisted Angioplasty in Symptomatic Intracranial Stenosis (ESASIS).
[44] Derdeyn, C.P., Videen, T.O., Simmons, N.R., Yundt, K.D., Fritsch, S.M., Grubb Jr., R.L., et al. (1999) Count-Based PET Method for Predicting Ischemic Stroke in Patients with Symptomatic Carotid Arterial Occlusion. Radiology, 212, 499-506.
[45] Dorros, G., Cohn, J.M. and Palmer, L.E. (1998) Stent Deployment Resolves a Petrous Carotid Artery Angioplasty Dissection. American Journal of Neuroradiology, 19, 392-394.
[46] Phatouros, C.C., Higashida, R.T., Malek, A.M., Smith, W.S., Mully, T.W., DeArmond, S.J., et al. (1999) Endovascular Stenting of an Acutely Thrombosed Basilar Artery: Technical Case Report and Review of the Literature. Neurosurgery, 44, 667-673.
[47] Morris, P.P., Martin, E.M., Regan, J. and Braden, G. (1999) Intracranial Deployment of Coronary Stents for Symptomatic Atherosclerotic Disease. American Journal of Neuroradiology, 20, 1688-1694.
[48] Yu, W., Smith, W.S., Singh, V., Ko, N.U., Cullen, S.P. and Dowd, C.F. (2005) Long-Term Outcome of Endovascular Stenting for Symptomatic Basilar Artery Stenosis. Neurology, 64, 1055-1057.
[49] Gomez, C.R., Misra, V.K., Liu, M.W., Wadlington, V.R., Terry, J.B. and Tulyapronchote, R. (2000) Elective Stenting of Symptomatic Basilar Artery Stenosis. Stroke, 31, 95-99.
[50] Mazighi, M., Yadav, J.S. and Abou-Chebl, A. (2008) Durability of Endovascular Therapy for Symptomatic Intracranial Atherosclerosis. Stroke, 39, 1766-1769.
[51] SSYLVIA Study Investigators (2004) Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA) Study Results. Stroke, 35, 1388-1392.
[52] Lutsep, H.L. (2009) Symptomatic Intracranial Stenosis: Best Medical Treatment vs. Intracranial Stenting. Current Opinion in Neurology, 22, 69-74.
[53] Steinfort, B., Ng, P.P., Faulder, K., Harrington, T., Grinnell, V., Sorby, W., et al. (2007) Midterm Outcomes of Paclitaxel-Eluting Stents for the Treatment of Intracranial Posterior Circulation Stenoses. Journal of Neurosurgery, 106, 222-225.
[54] Qureshi, A.I., Kirmani, J.F., Hussein, H.M., Harris-Lane, P., Divani, A.A., Suri, M.F., et al. (2006) Early and Intermediate-Term Outcomes with Drug-Eluting Stents in High-Risk Patients with Symptomatic Intracranial Stenosis. Neurosurgery, 59, 1044-1051.
[55] Abou-Chebl, A., Bashir, Q. and Yadav, J.S. (2005) Drug-Eluting Stents for the Treatment of Intracranial Atherosclerosis: Initial Experience and Midterm Angiographic Follow-Up. Stroke, 36, e165-e168.
[56] Gupta, R., Al-Ali, F., Thomas, A.J., Horowitz, M.B., Barrow, T., Vora, N.A., et al. (2006) Safety, Feasibility, and Short-Term Follow-Up of Drug-Eluting Stent Placement in the Intracranial and Extracranial Circulation. Stroke, 37, 2562-2566.
[57] Natarajan, S.K., Ogilvy, C.S., Hopkins, L.N., Siddiqui, A.H. and Levy, E.I. (2010) Initial Experience with an Everolimus-Eluting, Second-Generation Drug-Eluting Stent for Treatment of Intracranial Atherosclerosis. Journal of NeuroInterventional Surgery, 2, 104-109.
[58] Rahme, R.J., Aoun, S.G., Batjer, H.H. and Bendok, B.R. (2011) SAMMPRIS: End of Intracranial Stenting for Atherosclerosis or Back to the Drawing Board? Neurosurgery, 69, N16-N18.
[59] Benesch, C.G. and Chimowitz, M.I. (2000) Best Treatment for Intracranial Arterial Stenosis? Neurology, 55, 465-466.
[60] Fiorella, D.J., Turk, A.S., Levy, E.I., Pride Jr., G.L., Woo, H.H., Albuquerque, F.C., et al. (2011) US Wingspan Registry. Stroke, 42, 1976-1981.
[61] Jiang, W.J., Cheng-Ching, E., Abou-Chebl, A., Zaidat, O.O., Jovin, T.G., Kalia, J., et al. (2012) Multicenter Analysis of Stenting in Symptomatic Intracranial Atherosclerosis. Neurosurgery, 70, 25-31.
[62] Higashida, R.T., Tsai, F.Y., Halbach, V.V., Dowd, C.F., Smith, T., Fraser, K., et al. (1993) Transluminal Angioplasty for Atherosclerotic Disease of the Vertebral and Basilar Arteries. Journal of Neurosurgery, 78, 192-198.
[63] Terada, T., Higashida, R.T., Halbach, V.V., Dowd, C.F., Nakai, E., Yokote, H., et al. (1996) Transluminal Angioplasty for Arteriosclerotic Disease of the Distal Vertebral and Basilar Arteries. Journal of Neurology, Neurosurgery & Psychiatry, 60, 377-381.
[64] Takis, C., Kwan, E.S., Pessin, M.S., Jacobs, D.H. and Caplan, L.R. (1997) Intracranial Angioplasty: Experience and Complications. American Journal of Neuroradiology, 18, 1661-1668.
[65] Grubb, R.L., Derdeyn, C.P., Fritsch, S.M., Carpenter, D.A., Yundt, K.D., Videen, T.O., et al. (1998) Importance of Hemodynamic Factors in the Prognosis of Symptomatic Carotid Occlusion. JAMA: The Journal of the American Medical Association, 280, 1055-1060.
[66] Carlson, A.P., Yonas, H., Chang, Y.F. and Nemoto, E.M. (2011) Failure of Cerebral Hemodynamic Selection in General or of Specific Positron Emission Tomography Methodology? Carotid Occlusion Surgery Study (COSS). Stroke, 42, 3637-3639.
[67] (1985) Failure of Extracranial-Intracranial Arterial Bypass to Reduce the Risk of Ischemic Stroke. Results of an International Randomized Trial. The EC/IC Bypass Study Group. The New England Journal of Medicine, 313, 1191-200.
[68] Powers, W.J. (2012) Letter by Powers Regarding Article, “Failure of Cerebral Hemodynamic Selection in General or of Specific Positron Emission Tomography Methodology? Carotid Occlusion Surgery Study (COSS)”. Stroke, 43, e43.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.